Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | 390,803 | reported | 24 Feb 2026 | tx 21+5,102,710−67,907 |
| BRISTOL MYERS SQUIBB CO | 46,549 | reported | 31 Dec 2020 | tx 61+625,449−50,498 |
| Disc Medicine, Inc. | 20,000 | reported | 14 Jul 2025 | tx 1+20,000 |
| CELGENE CORP /DE/ | 0 | reported | 20 Nov 2019 | tx 51+85,913−247,980 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 13,515 | 14.47 USD | |
| 20 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 16,381 | 13.62 USD | |
| 18 Feb 2026 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 828,000 | 0.00 USD | deriv |
| 23 Dec 2025 | SALE | Cullinan Therapeutics, Inc. | 9,922 | 10.01 USD | |
| 14 Jul 2025 | GRANT_AWARD | Disc Medicine, Inc. | 20,000 | 0.00 USD | deriv |
| 25 Feb 2025 | SALE | Cullinan Therapeutics, Inc. | 12,529 | 8.53 USD | |
| 19 Feb 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 180,000 | 0.00 USD | |
| 19 Feb 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 360,000 | 0.00 USD | deriv |
| 24 Dec 2024 | SALE | Cullinan Therapeutics, Inc. | 8,400 | 11.87 USD | |
| 22 Feb 2024 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 160,000 | 0.00 USD | |
| 22 Feb 2024 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 320,000 | 0.00 USD | deriv |
| 26 Dec 2023 | SALE | Cullinan Therapeutics, Inc. | 4,272 | 9.24 USD | |
| 28 Jun 2023 | SALE | Cullinan Therapeutics, Inc. | 759 | 11.40 USD | |
| 23 May 2023 | SALE | Cullinan Therapeutics, Inc. | 707 | 9.15 USD | |
| 25 Apr 2023 | SALE | Cullinan Therapeutics, Inc. | 716 | 10.59 USD | |
| 23 Mar 2023 | SALE | Cullinan Therapeutics, Inc. | 706 | 10.51 USD | |
| 22 Feb 2023 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 109,000 | 0.00 USD | |
| 22 Feb 2023 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 211,000 | 0.00 USD | deriv |
| 30 Jun 2022 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 1,620 | 10.90 USD | |
| 06 Jun 2022 | PURCHASE | Cullinan Therapeutics, Inc. | 8,090 | 12.40 USD | |
| 05 Mar 2022 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 215,000 | 0.00 USD | deriv |
| 18 Oct 2021 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 2,710,000 | 0.00 USD | deriv |
| 31 Dec 2020 | TAX_WITHHOLDING | BRISTOL MYERS SQUIBB CO | 7,660 | 62.03 USD | |
| 31 Dec 2020 | EXERCISE | BRISTOL MYERS SQUIBB CO | 14,946 | 0.00 USD | |
| 31 Dec 2020 | EXERCISE | BRISTOL MYERS SQUIBB CO | 14,946 | 0.00 USD | deriv |